This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). Its unique structure, featuring a difluoromethyl group and a pyrrolidine ring, makes it valuable for developing drugs with enhanced metabolic stability and bioavailability. It is often employed in the production of protease inhibitors and other therapeutic agents targeting diseases such as cancer, viral infections, and autoimmune disorders. Additionally, its tert-butoxycarbonyl (Boc) protecting group allows for selective deprotection during multi-step synthetic processes, facilitating the creation of complex molecules. Its application is critical in medicinal chemistry for optimizing drug candidates and improving their pharmacokinetic properties.